The use of metoprolol and glycopyrrolate to prevent hypotensive/bradycardic events during shoulder arthroscopy in the sitting position under interscalene block.
Sudden profound hypotensive and/or bradycardic events (HBE) have been reported in >20% of patients undergoing shoulder arthroscopy in the sitting position under interscalene block anesthesia. Retrospective studies suggest that the administration of beta-blockers is safe and may decrease the incidence of these episodes. We performed a randomized, prospective study to evaluate prophylaxis of these events. One hundred fifty patients were randomized to one of three groups (placebo; prophylactic metoprolol to achieve a heart rate <60 bpm or a maximal dose of 10 mg; or prophylactic glycopyrrolate to achieve a heart rate >100 bpm or a maximal dose of 6 microg/kg) immediately after the administration of the interscalene block. Blood pressure control was achieved with IV enalaprilat as needed. The incidence of HBE was 28% in the placebo group versus 5% in the metoprolol group (P = 0.004). The rate of 22% in the glycopyrrolate group was not significantly different from placebo. Preoperative heart rate and arterial blood pressure, intraoperative sedation score, IV fluids, and enalaprilat use were similar in those patients who had a HBE compared with those who did not. Many aspects of this clinical setting are similar to tilttable testing for patients with recurrent vasovagal syncope, in which beta-adrenergic blockade with metoprolol has also been shown to be effective. We conclude that the Bezold-Jarisch reflex is the most likely mechanism for these events.


CONCLUSIONS
Episodes of acute hypotension and bradycardia occur during shoulder arthroscopy in the sitting position under interscalene block. In this study, we demonstrate that metoprolol, but not glycopyrrolate, markedly decreases the incidence of these episodes when given prophylactically immediately after the administration of the block.
Liguori
G A
GA
Hospital for Special Surgery and Department of Anesthesiology, Cornell University Medical College, New York, New York 10021, USA.
Kahn
R L
RL
Gordon
J
J
Gordon
M A
MA
Urban
M K
MK
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001182:Arthroscopy / Q000009:adverse effects* / Q000379:methods; D001919:Bradycardia / Q000209:etiology / Q000517:prevention & control*; D004311:Double-Blind Method; D004724:Endoscopy / Q000009:adverse effects; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000209:etiology / Q000517:prevention & control*; D008790:Metoprolol / Q000627:therapeutic use*; D009407:Nerve Block / Q000009:adverse effects*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011187:Posture; D011446:Prospective Studies; D012785:Shoulder Joint / Q000601:surgery*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D010276:Parasympatholytics; D008790:Metoprolol; D006024:Glycopyrrolate